| Low-Dose Spironolactone Prevents Apoptosis Repressor With Caspase Recruitment Domain Degradation During Myocardial Infarction. | |
| | |
MedLine Citation:
|
PMID: 22508833 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Low-dose mineralocorticoid receptor antagonists reduce morbidity and mortality in patients with heart failure and myocardial infarction, despite normal plasma aldosterone levels. Since apoptosis plays an important role in heart failure and postinfarction left ventricular remodeling, we examined whether low-dose mineralocorticoid receptor antagonists modulate cardiomyocyte death by regulating the apoptosis repressor protein apoptosis repressor with caspase recruitment domain to lessen the extent of apoptosis. Hearts from adult male Sprague-Dawley rats were subjected to regional ischemia followed by reperfusion ex vivo, with mineralocorticoid receptor antagonists added to perfusates before ischemia. Low-dose spironolactone (10 nmol/L) or eplerenone (100 nmol/L) significantly reduced infarct size. Spironolactone also prevented cleavage of the apoptotic chromatin condensation inducer in the nucleus and of the inhibitor of caspase-activated DNAse induced by ischemia-reperfusion, thereby abolishing chromatin condensation and internucleosomal cleavage. Ischemia-reperfusion-induced activation of caspases 2, 3, and 9, but not caspase 8, was prevented by spironolactone, suggesting targeted regulation of the intrinsic pathway. Low-dose spironolactone and eplerenone prevented loss of the apoptosis repressor with the caspase recruitment domain and reduced myocyte death. In H9c2 cells, mineralocorticoid receptor activation by aldosterone resulted in apoptosis repressor with caspase recruitment domain degradation and enhanced apoptosis; these actions were prevented by coadministration of spironolactone. Using a triple lysine mutant we identified that aldosterone enhances posttranscriptional degradation of the apoptosis repressor with a caspase recruitment domain via the ubiquitin-proteasomal pathway. Our data demonstrate that low-dose mineralocorticoid receptor antagonists reduce infarct size and apoptosis in the reperfused myocardium by preventing the apoptosis repressor with caspase recruitment domain degradation. |
| | |
Authors:
|
Thi Yen Loan Le; Mahidi Mardini; Viive M Howell; John W Funder; Anthony W Ashton; Anastasia S Mihailidou |
Related Documents
:
|
10791173 - Molecular and cellular aspects of fibrosis following thermal injury. 17367553 - Fractal and image analysis of morphological changes in the actin cytoskeleton of neonat... 19189053 - Presenilin-dependent regulated intramembrane proteolysis and gamma-secretase activity. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-4-16 |
Journal Detail:
|
Title: Hypertension Volume: - ISSN: 1524-4563 ISO Abbreviation: - Publication Date: 2012 Apr |
Date Detail:
|
Created Date: 2012-4-17 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7906255 Medline TA: Hypertension Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Cardiology, Royal North Shore Hospital, Sydney, New South Wales, Australia; Cardiovascular and Hormonal Research Laboratory, Cardiology Division, Hormone and Cancer Division, and Division of Perinatal Research, Kolling Institute of Medical Research, Royal North Shore Hospital and the University of Sydney, Sydney, New South Wales, Australia; Department of Cardiology, Westmead Hospital, Sydney, New South Wales, Australia; and Prince Henry's Institute, Clayton, Victoria, Australia. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Left ventricular failure produces profound lung remodeling and pulmonary hypertension in mice: heart...
Next Document: Mechanisms of carbon monoxide attenuation of tubuloglomerular feedback.